Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-27 Purchase |
2024-10-01 5:54 pm |
Wave Life Sciences Ltd. | WVE | GSK plc 10% Owner |
2,791,930 | $8 | $22,335,440 | 16,775,691 (Indirect) |
View |
| 2023-12-07 Purchase |
2024-01-30 4:39 pm |
Wave Life Sciences Ltd. | WVE | GSK plc 10% Owner |
3,300,000 | $5 | $16,500,000 | 13,983,761 (Indirect) |
View |
| 2021-07-02 Purchase |
2021-07-06 4:38 pm |
CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner |
275,000 | $18 | $4,950,000 | 1,007,583 (Indirect) |
View |
| 2021-05-20 Sale |
2021-05-24 5:04 pm |
Innoviva Inc. | INVA | GLAXOSMITHKLINE PLC 10% Owner |
32,005,260 | $12.25 | $392,064,435 | 0 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 4:50 pm |
Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director |
150,000 | $18 | $2,700,000 | 1,183,663 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-01-30 4:34 pm |
N/A N/A |
Wave Life Sciences Ltd. | WVE | GSK PLC 10% Owner |
0 | $0 | 10,683,761 (Indirect) |
View |
Ownership |
2022-11-14 5:05 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | GSK PLC 10% Owner |
0 | $0 | 9,190,606 (Indirect) |
View |
Ownership |
2022-11-04 4:11 pm |
N/A N/A |
23andMe Holding Co. | ME | GSK PLC 10% Owner |
0 | $0 | 39,660,487 (Indirect) |
View |
| 2022-09-16 Other |
2022-09-20 4:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner |
269,061,000 | $0 | 9,644,807 (Indirect) |
View |
| 2022-09-16 Other |
2022-09-20 4:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner |
9,644,807 | $9.75 | 9,644,807 (Indirect) |
View |
| 2021-07-02 Conversion |
2021-07-06 4:38 pm |
N/A N/A |
CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner |
13,331,791 | $0 | 1,007,583 (Indirect) |
View |
Ownership |
2021-07-06 4:22 pm |
N/A N/A |
CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner |
0 | $0 | 700,772 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 6:14 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner |
30,253,189 | $0 | 30,253,189 (Indirect) |
View |
Ownership |
2021-06-17 5:56 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner |
0 | $0 | 30,253,189 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 4:50 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director |
13,016,132 | $0 | 1,183,663 (Indirect) |
View |
Ownership |
2021-02-11 9:04 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director 10% Owner |
0 | $0 | 1,033,663 (Indirect) |
View |